{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:11:41Z","timestamp":1790647901117,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.biomaterials.2008.04.035","type":"journal-article","created":{"date-parts":[[2008,5,13]],"date-time":"2008-05-13T04:12:40Z","timestamp":1210651960000},"page":"3376-3383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death"],"prefix":"10.1016","volume":"29","author":[{"given":"Ki Hyun","family":"Bae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyejung","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae Gwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2008.04.035_bib1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","volume":"5","author":"Ferrari","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib2","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib3","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jconrel.2004.02.003","article-title":"Folate receptor targeted biodegradable polymeric doxorubicin micelles","volume":"96","author":"Yoo","year":"2004","journal-title":"J Controlled Release"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib4","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1021\/bc034164r","article-title":"Nanogels for oligonucleotide delivery to the brain","volume":"15","author":"Vinogradov","year":"2004","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib5","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1021\/bc050146t","article-title":"Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione","volume":"16","author":"Kommareddy","year":"2005","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/adma.200501612","article-title":"Hydrogels in biology and medicine: from molecular principles to bionanotechnology","volume":"18","author":"Peppas","year":"2006","journal-title":"Adv Mater"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib7","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1021\/bm060182a","article-title":"Temperature-sensitive pluronic\/poly(ethylenimine) nanocapsules for thermally triggered disruption of intracellular endosomal compartment","volume":"7","author":"Choi","year":"2006","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jconrel.2007.09.011","article-title":"Thermally sensitive cationic polymer nanocapsules for specific cytosolic delivery and efficient gene silencing of siRNA: swelling induced physical disruption of endosome by cold shock","volume":"125","author":"Lee","year":"2008","journal-title":"J\u00a0Controlled Release"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib9","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/1521-3773(20020201)41:3<390::AID-ANIE390>3.0.CO;2-B","article-title":"Heparin-protein interactions","volume":"41","author":"Capila","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib10","doi-asserted-by":"crossref","first-page":"5242","DOI":"10.1016\/j.biomaterials.2006.05.018","article-title":"Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF","volume":"27","author":"Pike","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nrc842","article-title":"Roles of heparan-sulfate glycosaminoglycans in cancer","volume":"2","author":"Sasisekharan","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib12","first-page":"3000","article-title":"Heparin-steroid conjugates: new angiogenesis inhibitors with antitumor activity in mice","volume":"53","author":"Thorpe","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib13","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.061615598","article-title":"Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis","volume":"98","author":"Borsig","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib14","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1016\/j.biomaterials.2007.02.001","article-title":"The attenuation of experimental lung metastasis by a bile acid acylated-heparin derivative","volume":"28","author":"Park","year":"2007","journal-title":"Biomaterials"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib15","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.critrevonc.2006.07.007","article-title":"Mechanisms of heparin induced anti-cancer activity in experimental cancer models","volume":"61","author":"Niers","year":"2007","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib16","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.chembiol.2004.03.023","article-title":"Poly(\u03b2-amino ester)s promote cellular uptake of heparin and cancer cell death","volume":"11","author":"Berry","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.chembiol.2004.04.001","article-title":"Heparin-induced cancer cell death","volume":"11","author":"Linhardt","year":"2004","journal-title":"Chem Biol"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib18","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s11095-006-9190-3","article-title":"Antiangiogenic and apoptotic properties of a novel amphiphilic folate\u2013heparin\u2013lithocholate derivative having cellular internality for cancer therapy","volume":"24","author":"Yu","year":"2007","journal-title":"Pharm Res"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib19","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1021\/bc060119i","article-title":"PEG-assisted DNA solubilization in organic solvents for preparing cytosol specifically degradable PEG\/DNA nanogels","volume":"17","author":"Mok","year":"2006","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2008.01.033","article-title":"Dissolution of biomacromolecules in organic solvents\u00a0by nano-complexing with poly(ethylene glycol)","author":"Mok","year":"2008","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-2797(97)00146-4","article-title":"Glutathione: an overview of biosynthesis and modulation","volume":"112","author":"Anderson","year":"1998","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib22","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1021\/bm000142l","article-title":"Glutathione-sensitive stabilization of block copolymer micelles composed of antisense DNA and thiolated poly(ethylene glycol)-block-poly(l-lysine): a potential carrier for systemic delivery of antisense DNA","volume":"2","author":"Kakizawa","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0014-5793(79)80065-4","article-title":"Relationship between anticoagulant activity of heparin and susceptibility to periodate oxidation","volume":"97","author":"Fransson","year":"1979","journal-title":"FEBS Lett"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib24","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1021\/bm0701189","article-title":"Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules","volume":"8","author":"Tae","year":"2007","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib25","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1163\/156856206774879090","article-title":"PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor","volume":"17","author":"Tae","year":"2006","journal-title":"J\u00a0Biomater Sci Polym Ed"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib26","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1021\/ja00177a058","article-title":"Protein microencapsulation of nonaqueous liquids","volume":"112","author":"Suslick","year":"1990","journal-title":"J\u00a0Am Chem Soc"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib27","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1021\/ma00113a002","article-title":"Phase behavior of blends of poly(ethylene glycol) and partially neutralized poly(acrylic acid)","volume":"28","author":"Lu","year":"1995","journal-title":"Macromolecules"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib28","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1021\/bm010097x","article-title":"Terminally alkylated heparin. 2. Potent antiproliferative agent for vascular smooth muscle cells","volume":"2","author":"Gohda","year":"2001","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/35037710","article-title":"The biochemistry of apoptosis","volume":"407","author":"Hengartner","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.cellbio.15.1.269","article-title":"Biochemical pathways of caspase activation during apoptosis","volume":"15","author":"Budihardjo","year":"1999","journal-title":"Annu Rev Cell Dev Biol"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/cyto.990130802","article-title":"Features of apoptotic cells measured by flow cytometry","volume":"13","author":"Daryzynkiewicz","year":"1992","journal-title":"Cytometry"},{"key":"10.1016\/j.biomaterials.2008.04.035_bib32","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/(SICI)1096-8652(199906)61:2<90::AID-AJH2>3.0.CO;2-9","article-title":"Apoptotic effects of heparin on\u00a0lymphoblasts, neutrophils, and mononuclear cells: results of a preliminary in vitro study","volume":"61","author":"Erduran","year":"1999","journal-title":"Am J Hematol"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961208002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T15:02:18Z","timestamp":1758898938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961208002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":32,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0142961208002834"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.04.035","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis, characterization, and intracellular delivery of reducible heparin nanogels for apoptotic cell death","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2008.04.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}